Showing 1 - 10 of 89,708
Reference prices constitute a main determinant of patient health care reimbursement in many countries. We study the effects of a change from an "external" (based on a basket of prices in other countries) to an "internal" (based on comparable domestic products) reference price system. We find...
Persistent link: https://www.econbiz.de/10010339324
Reference prices constitute a main determinant of patient health care reimbursement in many countries. We study the effects of a change from an external (based on a basket of prices in other countries) to an internal (based on comparable domestic products) reference price system. We find that...
Persistent link: https://www.econbiz.de/10010293128
On April 1, 2005, Denmark changed the way references prices, a main determinant of reimbursements for pharmaceutical purchases, are calculated. The previous reference prices, which were based on average EU prices, were substituted to minimum domestic prices. Novel to the literature, we estimate...
Persistent link: https://www.econbiz.de/10010302596
cost containment worldwide. However, there is little empirical evidence on the optimal design of co-payment regulation. A …-oriented regulation can lead to substantial savings for consumers and healthcare systems. …
Persistent link: https://www.econbiz.de/10010343088
cost containment worldwide. However, there is little empirical evidence on the optimal design of co-payment regulation. A …-oriented regulation can lead to substantial savings for consumers and healthcare systems. …
Persistent link: https://www.econbiz.de/10010343092
cost containment worldwide. However, there is little empirical evidence on the optimal design of co-payment regulation. A …-oriented regulation can lead to substantial savings for consumers and healthcare systems. …
Persistent link: https://www.econbiz.de/10010337014
cost containment worldwide. However, there is little empirical evidence on the optimal design of co-payment regulation. A …-oriented regulation can lead to substantial savings for consumers and healthcare systems. …
Persistent link: https://www.econbiz.de/10010337034
On April 1, 2005, Denmark changed the way references prices, a main determinant of reimbursements for pharmaceutical purchases, are calculated. The previous reference prices, which were based on average EU prices, were substituted to minimum domestic prices. Novel to the literature, we estimate...
Persistent link: https://www.econbiz.de/10008694123
On April 1, 2005, Denmark changed the way references prices, a main determinant of reimbursements for pharmaceutical purchases, are calculated. The previous reference prices, which were based on average EU prices, were substituted to minimum domestic prices. Novel to the literature, we estimate...
Persistent link: https://www.econbiz.de/10008534454
Reference prices constitute a main determinant of patient health care reimbursement in many countries. We study the effects of a change from an external (based on a basket of prices in other countries) to an internal (based on comparable domestic products) reference price system. We find that...
Persistent link: https://www.econbiz.de/10010747498